Shari Annes | IR |
Rachel King | President, CEO & Director |
Brian Hahn | CFO & Secretary |
Helen Thackray | SVP, Clinical Development & Chief Medical Officer |
Yatin Suneja | SunTrust Robinson Humphrey |
Ritu Baral | Cowen and Company |
Biren Amina | Jefferies |
Jotin Marango | Roth Capital Partners |
Stephen Willey | Stifel, Nicolaus & Company |
Good morning, and thank you all for joining the GlycoMimetics call. [Operator Instructions]. I would now like to turn the call over to Shari Annes of the Investor Relations group at GlycoMimetics. Please go ahead.
Good morning.